COVID-19 Vaccination: Considerations for Public Health and Policy

Message from the Guest Editors

Research areas may include (but not limited to) the following:

1. COVID-19 vaccine acceptance, hesitancy, and refusal, including assessments of the evolving epidemiology and understating of individual, group–level and context-specific determinants of these phenomena.

2. Monitoring and continued development of COVID-19 vaccines, including efficacy and effectiveness of vaccines in the context of emerging variants, safety, booster doses, mixing and matching vaccines.

3. Public health and policy issues, including vaccine deployment, ensuring equitable access, communication strategies for encouraging vaccine uptake and introduction of vaccine passports.

Deadline for manuscript submissions: 31 August 2022

View PDF version of this announcement

 

Guest Editors
Dr. Jovana Stojanovic: stojanovic.jovana1988@gmail.com
Prof. Dr. Kim L. Lavoie: lavoie.kim@uqam.ca
Prof. Dr. Simon Bacon: simon.bacon@concordia.ca

Vaccines (ISSN 2076-393X) has had a 6-year history of publishing peer-reviewed state of the art research that advances the knowledge of immunology in human disease protection. Immunotherapeutics, prophylactic vaccines, immunomodulators, adjuvants and the global differences in regulatory affairs are some of the highlights of the research published that have shaped global health. Our open access policy allows all researchers and interested parties to immediately scrutinize the rigorous evidence our publications have to offer. We are proud to present the work and perspectives of many to contribute to future decisions concerning human health.